The agency said it will not take action against pharmacies making copies of Eli Lilly’s blockbuster drug while it reevaluates ...

Eli Lilly shares continue to soar thanks to its new weight loss drugs. With sales of Mounjaro and ZepBound continuing to ...

Pharmaceutical powerhouse Eli Lilly (NYSE: LLY) is having a terrific 2024. Shares have gained 58% so far this year, handily ...

To make $1 million in the stock market, you don't need to invest a fortune. But you'll definitely want to take the time to ...

New research estimates that expanded access to Ozempic and similar drugs could lead to 42,000 deaths prevented annually.

We recently published a list of 10 Best Medical Stocks to Buy Now. In this article, we are going to take a look at where Eli ...

In a year and a half, Eli Lilly (NYSE: LLY) has roughly doubled in value. It is now the most valuable pharmaceutical company in the world.

A new study reveals that glucagon-like peptide-1 receptor agonists (GLP-1), which include weight loss and diabetes med ...

Judge Karen Marston held that, despite plaintiffs' arguments to the contrary, marketing discovery is not relevant to the ...

Only 15% of those who start a glucagon-like peptide 1 (GLP-1) for weight loss are still taking it two years according to ...

This week marked the start of the third-quarter earnings season, with Johnson & Johnson exceeding Wall Street’s expectations.

Since 2021, the Obesity Action Coalition (OAC) has led a national public awareness campaign against weight bias with a goal ...